Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 11 | $331,067 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Jun 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Jun 2023 | Sale | 6,500 | 4.4537 | 28,949 | D |
02 May 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 May 2023 | Sale | 6,800 | 4.424 | 30,083 | D |
04 Apr 2023 17:03 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Apr 2023 | Sale | 6,700 | 3.691 | 24,730 | D |
03 Mar 2023 17:04 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Mar 2023 | Sale | 7,000 | 3.4243 | 23,970 | D |
03 Feb 2023 17:08 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Feb 2023 | Sale | 7,700 | 3.7923 | 29,201 | D |
04 Jan 2023 19:30 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 04 Jan 2023 | Sale | 6,970 | 3.1759 | 22,136 | D |
05 Dec 2022 16:35 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Dec 2022 | Sale | 9,400 | 3.9089 | 36,744 | D |
23 Nov 2022 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Oct 2022 | Sale A | 9,500 | 3.9061 | 37,108 | D |
03 Nov 2022 16:49 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Nov 2022 | Sale | 9,700 | 4.0263 | 39,055 | D |
04 Oct 2022 16:59 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Oct 2022 | Sale | 12,524 | 3.9167 | 49,053 | D |
04 Oct 2022 16:59 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 30 Sep 2022 | Sale | 2,468 | 4.0674 | 10,038 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)